Nexvet Biopharma plc (NASDAQ:NVET) Consolidated Diluted EPS Stands At $-2.2736

0

For the period ended 2015-06-30, Nexvet Biopharma plc (NASDAQ:NVET) delivered annual basic consolidated EPS of $-2.2736. In terms of quarterly performance, the basic consolidated EPS was $-2.2736 for the quarter ended 2015-06-30.

What about EPS from continuing operations?

Nexvet Biopharma plc (NASDAQ:NVET) produced $-2.2736 in basic EPS from continuing operations for the annual period ended 2015-06-30. For the quarter, basic EPS from continuing operations was $-2.2736 for the three-month period ended 2015-06-30.

how much did parent contribute in EPS?

Nexvet Biopharma plc (NASDAQ:NVET) received basic EPS boost of $-2.2736 from its parent company for the annual period ended 2015-06-30. For quarterly metrics, basic EPS contribution from the parent company was $-2.2736 for the three-month period ended 2015-06-30.

Basic net EPS

Nexvet Biopharma plc (NASDAQ:NVET) posted basic net EPS of $-2.27 for the annual period ended 2015-06-30. On quarterly basis, the basic net EPS for the quarter ended 2015-06-30 was $-2.27.

Consolidated diluted EPS

Nexvet Biopharma plc (NASDAQ:NVET) produced annual consolidated diluted EPS of $-2.2736 for the period ended 2015-06-30. But consolidated diluted EPS stood at $-2.2736 for the quarter ended 2015-06-30.

Basic diluted EPS

Basic diluted EPS of $-2.2736 came from continuing operation for the annual period ended 2015-06-30. In terms of quarterly performance, diluted EPS from continuing operations was $-2.2736 for the quarter ended 2015-06-30.

Net diluted EPS

The company posted net diluted EPS of $-2.27 for the annual period ended 2015-06-30. Coming to the quarter, it posted net diluted EPS of $-2.27 for the three-month period ended 2015-06-30.

Diluted EPS from parent

Nexvet Biopharma plc (NASDAQ:NVET) received diluted EPS boost of $-2.2736 from the parent company for the annual period ended 2015-06-30. For the quarter, diluted EPS from the parent was $-2.2736 for the quarter ended 2015-06-30.

For the annual period ended 2015-06-30, Nexvet Biopharma plc (NASDAQ:NVET) produced net basic EPS of $-2.27. On quarterly basis, it posted basic net EPS of $-2.27, which was for the three-month period ended 2015-06-30.

The annual average of the company’s basic shares outstanding was 5.215 for the period ended 2015-06-30. The quarterly average of basic shares outstanding was 5.215 for the quarter ended 2015-06-30.

The company had diluted shares outstanding of 5.215 for the annual period ended 2015-06-30 and 5.215 for the quarterly period ended 2015-06-30.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 9 times, 1 visits today)